Biotech / Medical : ArQule, Inc. (ARQL)


 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: scaram(o)uche who wrote (496)4/10/2012 10:01:47 AM
From: dr.praveenRead Replies (1) of 538
 
what did you do here rick:-) I wished they waited for 6m...

WOBURN, Mass.--(BUSINESS WIRE)--

ArQule, Inc. (NASDAQ: ARQL - News) today announced its intention to offer, subject to market and other conditions, 6 million shares of its common stock in an underwritten public offering. The Company also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Citigroup and Leerink Swann are acting as joint book-running managers for the offering.
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

Copyright © 1995-2013 Knight Sac Media. All rights reserved.